IVF Hartmann Holding AG
IVF Hartmann Holding AG provides medical consumer goods in Switzerland and internationally. It offers medical products, accident prevention and hygiene products, body care and personal hygiene, disinfection and cleaning supplies, housekeeping, and other tools, such as liquid soap dispensers. The company was formerly known as IVF and changed its name to IVF Hartmann Holding AG in 1993. The company… Read more
IVF Hartmann Holding AG (VBSN) - Net Assets
Latest net assets as of June 2025: CHF145.36 Million CHF
Based on the latest financial reports, IVF Hartmann Holding AG (VBSN) has net assets worth CHF145.36 Million CHF as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CHF180.92 Million) and total liabilities (CHF35.56 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CHF145.36 Million |
| % of Total Assets | 80.34% |
| Annual Growth Rate | 7.09% |
| 5-Year Change | 9.19% |
| 10-Year Change | 65.29% |
| Growth Volatility | 6.82 |
IVF Hartmann Holding AG - Net Assets Trend (2002–2024)
This chart illustrates how IVF Hartmann Holding AG's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for IVF Hartmann Holding AG (2002–2024)
The table below shows the annual net assets of IVF Hartmann Holding AG from 2002 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CHF152.00 Million | +0.41% |
| 2023-12-31 | CHF151.38 Million | +5.36% |
| 2022-12-31 | CHF143.67 Million | +4.86% |
| 2021-12-31 | CHF137.01 Million | -1.57% |
| 2020-12-31 | CHF139.20 Million | +9.28% |
| 2019-12-31 | CHF127.37 Million | +5.09% |
| 2018-12-31 | CHF121.20 Million | +7.13% |
| 2017-12-31 | CHF113.14 Million | +9.96% |
| 2016-12-31 | CHF102.89 Million | +11.88% |
| 2015-12-31 | CHF91.96 Million | +13.32% |
| 2014-12-31 | CHF81.15 Million | +15.45% |
| 2013-12-31 | CHF70.29 Million | +18.13% |
| 2012-12-31 | CHF59.50 Million | -11.21% |
| 2011-12-31 | CHF67.01 Million | +16.41% |
| 2010-12-31 | CHF57.57 Million | +18.76% |
| 2009-12-31 | CHF48.48 Million | +7.22% |
| 2007-12-31 | CHF45.21 Million | +10.39% |
| 2006-12-31 | CHF40.96 Million | +5.42% |
| 2005-12-31 | CHF38.85 Million | +4.80% |
| 2004-12-31 | CHF37.07 Million | +5.45% |
| 2003-12-31 | CHF35.16 Million | +4.39% |
| 2002-12-31 | CHF33.68 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to IVF Hartmann Holding AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 611.7% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CHF139.96 Million | 92.08% |
| Common Stock | CHF4.20 Million | 2.76% |
| Other Comprehensive Income | CHF7.84 Million | 5.16% |
| Total Equity | CHF152.00 Million | 100.00% |
IVF Hartmann Holding AG Competitors by Market Cap
The table below lists competitors of IVF Hartmann Holding AG ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
FENIX Resources Ltd
AU:FEX
|
$92.21 Million |
|
Aker Biomarine AS
OL:AKBM
|
$92.30 Million |
|
Investcorp Europe Acquisition I Corp
NASDAQ:IVCB
|
$92.36 Million |
|
Jiangsu GDK Biotechnology Co Ltd
SHG:688670
|
$92.38 Million |
|
Mammoth Energy Services Inc
NASDAQ:TUSK
|
$92.17 Million |
|
VERSES AI Inc.
OTCQX:VRSSF
|
$92.14 Million |
|
CBO Territoria S.A.
PA:CBOT
|
$92.13 Million |
|
MEDIFAST INC
NYSE:MED
|
$92.13 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in IVF Hartmann Holding AG's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 151,376,000 to 151,998,000, a change of 622,000 (0.4%).
- Net income of 20,302,000 contributed positively to equity growth.
- Dividend payments of 19,680,000 reduced retained earnings.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CHF20.30 Million | +13.36% |
| Dividends Paid | CHF19.68 Million | -12.95% |
| Total Change | CHF- | 0.41% |
Book Value vs Market Value Analysis
This analysis compares IVF Hartmann Holding AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.20x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 9.94x to 2.20x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2002-12-31 | CHF14.03 | CHF139.50 | x |
| 2003-12-31 | CHF14.65 | CHF139.50 | x |
| 2004-12-31 | CHF15.44 | CHF139.50 | x |
| 2005-12-31 | CHF16.18 | CHF139.50 | x |
| 2006-12-31 | CHF17.06 | CHF139.50 | x |
| 2007-12-31 | CHF18.84 | CHF139.50 | x |
| 2009-12-31 | CHF20.20 | CHF139.50 | x |
| 2010-12-31 | CHF23.99 | CHF139.50 | x |
| 2011-12-31 | CHF27.94 | CHF139.50 | x |
| 2012-12-31 | CHF24.78 | CHF139.50 | x |
| 2013-12-31 | CHF29.27 | CHF139.50 | x |
| 2014-12-31 | CHF33.79 | CHF139.50 | x |
| 2015-12-31 | CHF38.63 | CHF139.50 | x |
| 2016-12-31 | CHF43.24 | CHF139.50 | x |
| 2017-12-31 | CHF47.58 | CHF139.50 | x |
| 2018-12-31 | CHF51.00 | CHF139.50 | x |
| 2019-12-31 | CHF53.64 | CHF139.50 | x |
| 2020-12-31 | CHF58.62 | CHF139.50 | x |
| 2021-12-31 | CHF57.71 | CHF139.50 | x |
| 2022-12-31 | CHF60.52 | CHF139.50 | x |
| 2023-12-31 | CHF63.06 | CHF139.50 | x |
| 2024-12-31 | CHF63.34 | CHF139.50 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently IVF Hartmann Holding AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 13.36%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 12.79%
- • Asset Turnover: 0.84x
- • Equity Multiplier: 1.24x
- Recent ROE (13.36%) is below the historical average (14.31%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2002 | 9.87% | 3.25% | 1.32x | 2.30x | CHF-45.00K |
| 2003 | 10.67% | 3.45% | 1.39x | 2.23x | CHF234.20K |
| 2004 | 11.55% | 3.77% | 1.48x | 2.08x | CHF573.60K |
| 2005 | 11.38% | 4.08% | 1.45x | 1.92x | CHF537.80K |
| 2006 | 11.61% | 4.45% | 1.52x | 1.71x | CHF658.30K |
| 2007 | 13.69% | 5.95% | 1.62x | 1.42x | CHF1.67 Million |
| 2009 | 21.37% | 9.11% | 1.60x | 1.47x | CHF5.51 Million |
| 2010 | 21.51% | 10.53% | 1.43x | 1.43x | CHF6.62 Million |
| 2011 | 19.65% | 11.10% | 1.28x | 1.38x | CHF6.46 Million |
| 2012 | 24.90% | 11.76% | 1.47x | 1.44x | CHF8.86 Million |
| 2013 | 21.83% | 12.23% | 1.28x | 1.39x | CHF8.32 Million |
| 2014 | 19.44% | 11.87% | 1.25x | 1.31x | CHF7.66 Million |
| 2015 | 17.50% | 12.16% | 1.10x | 1.31x | CHF6.90 Million |
| 2016 | 15.99% | 12.21% | 1.03x | 1.27x | CHF6.16 Million |
| 2017 | 14.15% | 12.00% | 0.96x | 1.23x | CHF4.70 Million |
| 2018 | 11.61% | 10.50% | 0.90x | 1.23x | CHF1.95 Million |
| 2019 | 9.55% | 8.82% | 0.89x | 1.22x | CHF-568.40K |
| 2020 | 12.81% | 10.31% | 0.95x | 1.30x | CHF3.91 Million |
| 2021 | 4.53% | 4.31% | 0.83x | 1.26x | CHF-7.49 Million |
| 2022 | 7.81% | 7.45% | 0.84x | 1.26x | CHF-3.14 Million |
| 2023 | 10.01% | 10.24% | 0.78x | 1.25x | CHF10.40K |
| 2024 | 13.36% | 12.79% | 0.84x | 1.24x | CHF5.10 Million |
Industry Comparison
This section compares IVF Hartmann Holding AG's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $261,613,000
- Average return on equity (ROE) among peers: 9.23%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| IVF Hartmann Holding AG (VBSN) | CHF145.36 Million | 9.87% | 0.24x | $92.20 Million |
| SKAN Group AG (SKAN) | $82.55 Million | 5.49% | 2.14x | $650.24 Million |
| Tecan Group AG (TECN) | $440.67 Million | 12.97% | 0.46x | $1.68 Billion |